About Us

Re-Enjoying Life’s Simple Pleasures

Standing. Walking. Bathing. Sleeping. While these everyday activities are easy for most people, they can be monumental tasks for patients with chronic venous disease.

enVVeno Medical creates innovative medical devices to treat severe venous diseases. Our mission is to improve the lives of the approximately three million people living the US with severe deep venous insufficiency for which there are currently no effective treatment options. With one non-surgical replacement enVVe valve, the goal is for patients to reclaim their daily lives and to begin enjoying life’s simple pleasures again. 

Leadership Team
Board of Directors

Re-Enjoying Life’s Simple Pleasures

Standing. Walking. Bathing. Sleeping. While these everyday activities are easy for most people, they can be monumental tasks for patients with chronic venous disease.

enVVeno Medical creates innovative medical devices to treat severe venous diseases. Our mission is to improve the lives of the approximately three million people living the US with severe deep venous insufficiency for which there are currently no effective treatment options. With one non-surgical replacement enVVe valve, the goal is for patients to reclaim their daily lives and to begin enjoying life’s simple pleasures again. 

Leadership Team
Board of Directors

Join Our Mission to Transform Lives

Join Our Mission to Transform Lives

At enVVeno Medical, we’re not just developing medical devices, we’re pioneering treatments that redefine care for deep venous disease.

If you are driven by innovation, committed to excellence, and eager to make a tangible difference in the world of healthcare, we invite you to be part of our growing team.

Join enVVeno Medical

Latest Press Releases from enVVeno

About Us

enVVeno Medical (NASDAQ: NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company’s lead program, enVVe®, is a first-in-class, non-surgical replacement venous valve designed to treat severe Deep Venous Insufficiency (DVI), a debilitating condition caused by permanently damaged valves in the deep veins of the leg.

In severe DVI, permanently damaged valves in the deep veins of the leg lead to backward blood flow (reflux), blood pooling, elevated venous pressure, and, in advanced cases, painful and difficult-to-heal venous ulcers. The enVVe valve is designed to restore proper directional blood flow in the deep venous system through a minimally invasive, transcatheter-based procedure without the need for open surgery or an overnight hospital stay. enVVeno estimates that approximately 3 million people in the United States suffer from severe DVI with no effective options.

The enVVe System has received FDA Investigational Device Exemption (IDE) approval for its TAVVE pivotal clinical trial. The TAVVE study is a prospective, randomized, multi-center trial safety and measuring both hemodynamic improvement and clinical benefit in up to 220 patients across 40 clinical sites.